Publications

Publications

WHO/Victor Garstea
© Credits

Latest publications

All →
Operational considerations for collaborative surveillance: report of the Pan-European Network for Disease Control Collaborative Surveillance Working Group

This report presents operational considerations for implementing collaborative surveillance in the WHO European Region, developed by the Collaborative...

Barriers to and drivers of vaccination – insights and recommended actions: targeting low uptake of human papillomavirus vaccination and vaccination inequities in Georgia

In Georgia, despite maintaining high national coverage for measles, mumps and rubella (MMR) vaccination and for diphtheria, tetanus and pertussis vaccinations...

Governance and capacities for environment and health in the WHO European Region

Environment and health governance refers to the systems, structures and processes that guide decision making and implementation of policies to reduce environmental...

Community mapping in health emergencies: strengthening preparedness, response and resilience

This document provides a comprehensive toolkit for community mapping to support emergency preparedness and responses for public health emergencies as defined...



Latest documents

All →

Tuberculosis and malnutrition factsheet

Overview

TB remains an important cause of mortality and morbidity in the WHO European Region and worldwide. Rates of drug-resistant TB are increasing globally. Malnutrition has significant interactions with the TB disease process and may be an important therapeutic target. There is a bidirectional relationship between TB and malnutrition: malnourished individuals are at greater risk of contracting TB, and TB is a catabolic disease that can cause or exacerbate malnutrition. TB patients who are malnourished experience poorer outcomes, which are more pronounced in those with RR/MDR-TB. Malnutrition impairs immune system function in multiple ways, and this may underpin some of the observed relationships. Furthermore, malnutrition can influence how drugs are absorbed and processed, causing treatment failure and downstream effects on treatment toxicity rates in TB patients.

WHO Team
Special Initiative on NCDs and Innovation (SNI)
Number of pages
10